Form 4: Cardlytics Director Scott A. Hill Acquires 11,000 Restricted Stock Units

Director Scott A. Hill acquired 11,000 restricted stock units in Cardlytics, Inc. on May 20, 2025, which will vest in full on the one-year anniversary of the grant date.

Summary

• On May 20, 2025, Scott A. Hill, a director of Cardlytics, Inc., acquired 11,000 Restricted Stock Units (RSUs).
• Each RSU represents a contingent right to receive one share of Cardlytics common stock or its cash equivalent, at the Issuer's election.
• The RSUs will vest in full on May 20, 2026, provided Hill remains a director of Cardlytics on that date.
• The transaction was reported on a Form 4 filing with the SEC.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock units granted to a director. It doesn't inherently indicate positive or negative sentiment, but rather a routine part of executive compensation.

Positives

• The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs will vest in full on the one-year anniversary of the grant date, provided that the Reporting Person remains a director of the Issuer on such vesting date.

Industry Context

Form 4 filings are routine disclosures required by the SEC when company insiders, such as directors and officers, trade in their company's stock. These filings provide transparency to the market and allow investors to track insider activity, which can sometimes offer insights into a company's prospects.

Stakeholder Impact

• The acquisition of RSUs by a director could be viewed positively by shareholders as it aligns the director's interests with the company's long-term success.

Key Dates

Keywords

Cardlytics, Director, Scott A. Hill, Restricted Stock Units, RSUs, Form 4, SEC Filing, Beneficial Ownership, Equity Securities, Vesting